These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22886625)
1. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Jin YJ; Termsarasab U; Ko SH; Shim JS; Chong S; Chung SJ; Shim CK; Cho HJ; Kim DD Pharm Res; 2012 Dec; 29(12):3443-54. PubMed ID: 22886625 [TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664 [TBL] [Abstract][Full Text] [Related]
3. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery. Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor. Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706 [TBL] [Abstract][Full Text] [Related]
5. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169 [TBL] [Abstract][Full Text] [Related]
7. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes. Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
10. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model. Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161 [TBL] [Abstract][Full Text] [Related]
11. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
12. Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats. Chang JE; Shim WS; Yang SG; Kwak EY; Chong S; Kim DD; Chung SJ; Shim CK Pharm Res; 2012 Mar; 29(3):795-805. PubMed ID: 21971829 [TBL] [Abstract][Full Text] [Related]
13. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748 [TBL] [Abstract][Full Text] [Related]
14. A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis. Wei Z; Wang H; Xin G; Zeng Z; Li S; Ming Y; Zhang X; Xing Z; Li L; Li Y; Zhang B; Zhang J; Niu H; Huang W Int J Nanomedicine; 2020; 15():6545-6560. PubMed ID: 32943867 [TBL] [Abstract][Full Text] [Related]
15. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260 [TBL] [Abstract][Full Text] [Related]
17. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060 [TBL] [Abstract][Full Text] [Related]
18. Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Dai W; Yang T; Wang Y; Wang X; Wang J; Zhang X; Zhang Q Nanomedicine; 2012 Oct; 8(7):1152-61. PubMed ID: 22306158 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer. Liu Y; Zhao J; Jiang J; Chen F; Fang X Int J Nanomedicine; 2020; 15():2873-2884. PubMed ID: 32368059 [TBL] [Abstract][Full Text] [Related]
20. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]